Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Where, When, and How? Integrating Spatiotemporal Cues in Cell Division. | Bioessays | 2026 | 41311165 | PubTator, text mining | PubMed |
| Survivin and Aurora Kinase A control cell fate decisions during mitosis. | Mol Oncol | 2026 | 41076569 | PubTator, text mining | PubMed |
| PTTG1-mediated reprogramming of asparagine metabolism enhances DNA damage repair and leads to compromised antitumor immunity in prostate cancer. | Urol Oncol | 2026 | 41033896 | PubTator, text mining | PubMed |
| PTTG1 as a common promising target for PCOS, Ovarian Cancer, and Major Depressive Disorder patients. | Comput Biol Chem | 2026 | 40925190 | PubTator, text mining | PubMed |
| Identification of unique biomarkers in colorectal cancer based on comprehensive analysis and machine learning. | Front Oncol | 2025 | 41669255 | PubTator, text mining | PubMed |
| Integrative Bioinformatics and Experimental Validation Establish CCNB1 as a Potential Biomarker for Diagnosis and Prognosis in Colorectal Cancer. | Curr Issues Mol Biol | 2025 | 41614789 | PubTator, text mining | PubMed |
| Are PTTG1 variants associated with tumor characteristics and p53/Ki-67 expression in pituitary neuroendocrine tumors. | Front Endocrinol (Lausanne) | 2025 | 41573212 | PubTator, text mining | PubMed |
| Tumor prognostic risk stratification based on pseudo-time analysis of single-cell sequencing for patients with lung adenocarcinoma. | J Thorac Dis | 2025 | 41522114 | PubTator, text mining | PubMed |
| Novel common target genes for breast cancer and colorectal cancer: a Mendelian randomization and spatial transcriptomics study. | Discov Oncol | 2025 | 41427984 | PubTator, text mining | PubMed |
| Construction and validation of an oxidative phosphorylation-related gene signature in lung squamous cell carcinoma patients. | Lung Cancer Manag | 2025 | 41343408 | PubTator, text mining | PubMed |
| Emerging Roles of PTTG1/Securin in Breast Cancer. | J Cancer | 2025 | 41323790 | PubTator, text mining | PubMed |
| Multi-omics integration identifies ASPH and PTTG1 as potential causal drivers of lung adenocarcinoma progression and immune evasion. | Front Immunol | 2025 | 41312363 | PubTator, text mining | PubMed |
| Prediction of prognostic biomarkers for hepatocellular carcinoma and immune microenvironment infiltration based on single-cell sequencing and RNA-Seq integration. | Discov Oncol | 2025 | 41276703 | PubTator, text mining | PubMed |
| Inhibition of PTTG1 suppresses proliferation and promotes differentiation of neuroblastoma cells by inducing autophagy. | Pediatr Surg Int | 2025 | 41264123 | PubTator, text mining | PubMed |
| Prognostic significance of key immune cell functional alterations in clear cell renal cell carcinoma. | Transl Cancer Res | 2025 | 41234823 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of the Tumor Microenvironment in High-Grade Serous Carcinoma: A Pilot Study of Morphologic and Molecular Distinctions Between Classic and SET Patterns. | Int J Mol Sci | 2025 | 41155518 | PubTator, text mining | PubMed |
| Enzymatic Inhibitors of Aspartyl Protease EAP1 and Xylanase SRXL1 from Sporisorium reilianum Isolated from Corn Seeds. | Int J Mol Sci | 2025 | 41155266 | PubTator, text mining | PubMed |
| SET8 modulates prognosis and radiotherapeutic efficacy by regulating radiation-induced migration in lung adenocarcinoma. | J Transl Med | 2025 | 41029392 | PubTator, text mining | PubMed |
| Identification of the Immune Microenvironment, Mutation Burden, Immunotherapy, and Drug Sensitivity Related to Lung Adenocarcinoma Tumor Stem Cells via WGCNA. | Curr Cancer Drug Targets | 2025 | 41029019 | PubTator, text mining | PubMed |
| Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers. | Int J Mol Sci | 2025 | 41009526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=3